|
1
|
Aubert G and Lansdorp PM: Telomeres and
aging. Physiol Rev. 88:557–579. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Blackburn EH: Switching and signaling at
the telomere. Cell. 106:661–673. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Harley CB, Futcher AB and Greider CW:
Telomeres shorten during ageing of human fibroblasts. Nature.
345:458–460. 1990. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
von Zglinicki T: Oxidative stress shortens
telomeres. Trends Biochem Sci. 27:339–344. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Artandi SE and DePinho RA: Telomeres and
telomerase in cancer. Carcinogenesis. 31:9–18. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Blasco MA: Telomeres and human disease:
Ageing, cancer and beyond. Nat Rev Genet. 6:611–622. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Furugori E, Hirayama R, Nakamura KI,
Kammori M, Esaki Y and Takubo K: Telomere shortening in gastric
carcinoma with aging despite telomerase activation. J Cancer Res
Clin Oncol. 126:481–485. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kammori M, Takubo K, Nakamura K, Furugouri
E, Endo H, Kanauchi H, Mimura Y and Kaminishi M: Telomerase
activity and telomere length in benign and malignant human thyroid
tissues. Cancer Lett. 159:175–181. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Broberg K, Björk J, Paulsson K, Höglund M
and Albin M: Constitutional short telomeres are strong genetic
susceptibility markers for bladder cancer. Carcinogenesis.
26:1263–1271. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakamura K, Furugori E, Esaki Y, Arai T,
Sawabe M, Okayasu I, Fujiwara M, Kammori M, Mafune K, Kato M, et
al: Correlation of telomere lengths in normal and cancers tissue in
the large bowel. Cancer Lett. 158:179–184. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
O'Sullivan JN, Bronner MP, Brentnall TA,
Finley JC, Shen WT, Emerson S, Emond MJ, Gollahon KA, Moskovitz AH,
Crispin DA, et al: Chromosomal instability in ulcerative colitis is
related to telomere shortening. Nat Genet. 32:280–284. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Firnhaber JM: Diagnosis and treatment of
Basal cell and squamous cell carcinoma. Am Fam Physician.
86:161–168. 2012.PubMed/NCBI
|
|
13
|
Yanofsky VR, Mercer SE and Phelps RG:
Histopathological variants of cutaneous squamous cell carcinoma: A
review. J Skin Cancer. 2011:2108132011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Röwert-Huber J, Patel MJ, Forschner T,
Ulrich C, Eberle J, Kerl H, Sterry W and Stockfleth E: Actinic
keratosis is an early in situ squamous cell carcinoma: A proposal
for reclassification. Br J Dermatol. 3(156 Suppl): S8–S12. 2007.
View Article : Google Scholar
|
|
15
|
Glogau RG: The risk of progression to
invasive disease. J Am Acad Dermatol. 42:23–24. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim RH and Armstrong AW: Nonmelanoma skin
cancer. Dermatol Clin. 30:125–139. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wainwright LJ, Middleton PG and Rees JL:
Changes in mean telomere length in basal cell carcinomas of the
skin. Genes Chromosomes Cancer. 12:45–49. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Parris CN, Jezzard S, Silver A, MacKie R,
McGregor JM and Newbold RF: Telomerase activity in melanoma and
non-melanoma skin cancer. Br J Cancer. 79:47–53. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Han J, Qureshi AA, Prescott J, Guo Q, Ye
L, Hunter DJ and De Vivo I: A prospective study of telomere length
and the risk of skin cancer. J Invest Dermatol. 129:415–421. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Leufke C, Leykauf J, Krunic D, Jauch A,
Holtgreve-Grez H, Böhm-Steuer B, Bröcker EB, Mauch C, Utikal J,
Hartschuh W, et al: The telomere profile distinguishes two classes
of genetically distinct cutaneous squamous cell carcinomas.
Oncogene. 33:3506–3518. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aida J, Izumiyama-Shimomura N, Nakamura K,
Ishii A, Ishikawa N, Honma N, Kurabayashi R, Kammori M, Poon SS and
Arai T: Telomere length variations in 6 mucosal cell types of
gastric tissue observed using a novel quantitative fluorescence in
situ hybridization method. Hum Pathol. 38:1192–1200. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kammori M, Izumiyama N, Nakamura K,
Kurabayashi R, Kashio M, Aida J, Poon SS and Kaminishi M: Telomere
metabolism and diagnostic demonstration of telomere measurement in
the human esophagus for distinguishing benign from malignant tissue
by tissue quantitative fluorescence in situ hybridization.
Oncology. 71:430–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sugishita Y, Kammori M, Yamada O, Yamazaki
K, Ito K, Fukumori T, Yoshikawa K and Yamada T: Biological
differential diagnosis of follicular thyroid tumor and Hurthle cell
tumor on the basis of telomere length and hTERT expression. Ann
Surg Oncol. 21:2318–2325. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kurabayashi R, Takubo K, Aida J, Honma N,
Poon SS, Kammori M, Izumiyama-Shimomura N, Nakamura K, Tsuji E,
Matsuura M, et al: Luminal and cancer cells in the breast show more
rapid telomere shortening than myoepithelial cells and fibroblasts.
Hum Pathol. 39:1647–1655. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sugishita Y, Kammori M, Yamada O, Poon SS,
Kobayashi M, Onoda N, Yamazaki K, Fukumori T, Yoshikawa K, Onose H,
et al: Amplification of the human epidermal growth factor receptor
2 gene in differentiated thyroid cancer correlates with telomere
shortening. Int J Oncol. 42:1589–1596. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ikeda H, Aida J, Hatamochi A, Hamasaki Y,
Izumiyama-Shimomura N, Nakamura K, Ishikawa N, Poon SS, Fujiwara M,
Tomita K, et al: Quantitative fluorescence in situ hybridization
measurement of telomere length in skin with/without sun exposure or
actinic keratosis. Hum Pathol. 45:473–480. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Buckingham EM and Klingelhutz AJ: The role
of telomeres in the ageing of human skin. Exp Dermatol. 20:297–302.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Aida J, Izumo T, Shimomura N, Nakamura K,
Ishikawa N, Matsuura M, Poon SS, Fujiwara M, Sawabe M, Arai T and
Takubo K: Telomere lengths in the oral epithelia with and without
carcinoma. Eur J Cancer. 46:430–438. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kuhn E, Meeker A, Wang TL, Sehdev AS,
Kurman RJ and Ie M Shih: Shortened telomeres in serous tubal
intraepithelial carcinoma: An early event in ovarian high-grade
serous carcinogenesis. Am J Surg Pathol. 34:829–836. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Czarnecki D, Meehan CJ, Bruce F and Culjak
G: The majority of cutaneous squamous cell carcinomas arise in
actinic keratoses. J Cutan Med Surg. 6:207–209. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fu W and Cockerell CJ: The actinic (solar)
keratosis: A 21st-century perspective. Arch Dermatol. 139:66–70.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cassarino DS, Derienzo DP and Barr RJ:
Cutaneous squamous cell carcinoma: A comprehensive
clinicopathologic classification-part two. J Cutan Pathol.
33:261–279. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ra SH, Li X and Binder S: Molecular
discrimination of cutaneous squamous cell carcinoma from actinic
keratosis and normal skin. Mod Pathol. 24:963–973. 2011.PubMed/NCBI
|
